EBV再激活和淋巴发育:更多的问题而不是答案
Maegan Ford1, Evelyn Orlando2, Jennifer Effie Amengual3
1Division of Pediatric Hematology, Oncology, and Stem Cell Transplant, Columbia University Irving Medical Center, New York, NY, 10032, USA.
爱斯坦-巴尔病毒 (EBV) 重活化缺乏标准化的监测和治疗方案. 需要进行研究,为高风险人群制定有效的策略,并管理EBV驱动的淋巴增殖.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 爱斯坦-巴尔病毒 (EBV) 建立了终身的B淋巴细胞感染,具有潜伏和溶解阶段.
- 在免疫能力和免疫功能低下的个体中,EBV的重新激活会导致淋巴增殖.
- 目前的文献缺乏标准化的EBV监测和治疗方案.
研究的目的:
- 审查目前抑制EBV复制的策略,并讨论对标准化监测和治疗方案的需求.
- 突出新兴疗法和正在进行的临床试验,以治疗与EBV相关的疾病.
主要方法:
- 关于EBV复制抑制策略的文献综述.
- 对当前治疗方法和临床试验的分析.
- 确定EBV管理中的研究缺口.
主要成果:
- 没有FDA批准的EBV疗法存在;策略包括免疫抑制降低,核糖类相似物,HDAC抑制剂,EBV特异性CTL和单克隆抗体.
- 一个正在进行的试验结合了HDAC抑制剂纳米氨基和甘西克洛维尔用于耐火/复发的EBV淋巴瘤.
- 针对EBV的T细胞免疫疗法Tabelecleucel在欧盟获得批准,并在美国对EBV阳性PTLD有限使用.
结论:
- 进一步的研究对于在高风险人群 (自身免疫性疾病,癌症,艾滋病毒,免疫抑制个体) 中建立EBV监测协议至关重要.
- 迫切需要用于预防和治疗EBV再激活和淋巴增殖的标准化治疗方法.
更多相关视频
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
09:43An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
相关概念视频
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Mechanisms of Retrovirus-induced Cancers
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Cells of the Adaptive Immune Response
Non-LTR Retrotransposons
